世界の乳がん再発スコア検査市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Breast Cancer Recurrence Score Test Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5112 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、乳がん再発スコア検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（I期の浸潤性乳がん、II期の浸潤性乳がん、エストロゲン受容体陽性がん、リンパ節転移陰性乳がん）、用途別市場規模（病院、専門がんセンター、高度診断センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・乳がん再発スコア検査の市場動向 ・企業の競争状況、市場シェア ・乳がん再発スコア検査の種類別市場規模と予測2016-2027（I期の浸潤性乳がん、II期の浸潤性乳がん、エストロゲン受容体陽性がん、リンパ節転移陰性乳がん） ・乳がん再発スコア検査の用途別市場規模と予測2016-2027（病院、専門がんセンター、高度診断センター、その他） ・乳がん再発スコア検査の北米市場規模2016-2027（アメリカ、カナダ） ・乳がん再発スコア検査の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・乳がん再発スコア検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・乳がん再発スコア検査の中南米市場規模2016-2027（メキシコ、ブラジル） ・乳がん再発スコア検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Roche Diagnostics、Braster、Bremed、Forward Science Technologies、Guided Therapeutics、Varian Medical Systems、LED Dental、PWB Health、Zilico Medical Diagnostics） ・結論

The breast cancer recurrence score test is a genomic test that extracts breast cancer tissue during surgery to check the activity of certain genes related to breast cancer, which is very helpful for the treatment of breast cancer. In addition, the breast cancer recurrence score test can also estimate the risk of early breast cancer.

Market Analysis and Insights: Global Breast Cancer Recurrence Score Test Market
The global Breast Cancer Recurrence Score Test market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Breast Cancer Recurrence Score Test market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Breast Cancer Recurrence Score Test market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Breast Cancer Recurrence Score Test market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Breast Cancer Recurrence Score Test market.

Global Breast Cancer Recurrence Score Test Scope and Market Size
Breast Cancer Recurrence Score Test market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Breast Cancer Recurrence Score Test market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Stage I Invasive Breast Cancer
Stage II Invasive Breast Cancer
Estrogen Receptor-positive Cancer
Lymph Node-negative Breast Cancer

Segment by Application
Hospitals
Speciality Cancer Centers
Advanced Diagnostic Centers
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Roche Diagnostics
Braster
Bremed
Forward Science Technologies
Guided Therapeutics
Varian Medical Systems
LED Dental
PWB Health
Zilico Medical Diagnostics

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Breast Cancer Recurrence Score Test Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Stage I Invasive Breast Cancer
1.2.3 Stage II Invasive Breast Cancer
1.2.4 Estrogen Receptor-positive Cancer
1.2.5 Lymph Node-negative Breast Cancer
1.3 Market by Application
1.3.1 Global Breast Cancer Recurrence Score Test Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Speciality Cancer Centers
1.3.4 Advanced Diagnostic Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Breast Cancer Recurrence Score Test Market Perspective (2016-2027)
2.2 Breast Cancer Recurrence Score Test Growth Trends by Regions
2.2.1 Breast Cancer Recurrence Score Test Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Breast Cancer Recurrence Score Test Historic Market Share by Regions (2016-2021)
2.2.3 Breast Cancer Recurrence Score Test Forecasted Market Size by Regions (2022-2027)
2.3 Breast Cancer Recurrence Score Test Industry Dynamic
2.3.1 Breast Cancer Recurrence Score Test Market Trends
2.3.2 Breast Cancer Recurrence Score Test Market Drivers
2.3.3 Breast Cancer Recurrence Score Test Market Challenges
2.3.4 Breast Cancer Recurrence Score Test Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Breast Cancer Recurrence Score Test Players by Revenue
3.1.1 Global Top Breast Cancer Recurrence Score Test Players by Revenue (2016-2021)
3.1.2 Global Breast Cancer Recurrence Score Test Revenue Market Share by Players (2016-2021)
3.2 Global Breast Cancer Recurrence Score Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Breast Cancer Recurrence Score Test Revenue
3.4 Global Breast Cancer Recurrence Score Test Market Concentration Ratio
3.4.1 Global Breast Cancer Recurrence Score Test Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Breast Cancer Recurrence Score Test Revenue in 2020
3.5 Breast Cancer Recurrence Score Test Key Players Head office and Area Served
3.6 Key Players Breast Cancer Recurrence Score Test Product Solution and Service
3.7 Date of Enter into Breast Cancer Recurrence Score Test Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Breast Cancer Recurrence Score Test Breakdown Data by Type
4.1 Global Breast Cancer Recurrence Score Test Historic Market Size by Type (2016-2021)
4.2 Global Breast Cancer Recurrence Score Test Forecasted Market Size by Type (2022-2027)

5 Breast Cancer Recurrence Score Test Breakdown Data by Application
5.1 Global Breast Cancer Recurrence Score Test Historic Market Size by Application (2016-2021)
5.2 Global Breast Cancer Recurrence Score Test Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Breast Cancer Recurrence Score Test Market Size (2016-2027)
6.2 North America Breast Cancer Recurrence Score Test Market Size by Type
6.2.1 North America Breast Cancer Recurrence Score Test Market Size by Type (2016-2021)
6.2.2 North America Breast Cancer Recurrence Score Test Market Size by Type (2022-2027)
6.2.3 North America Breast Cancer Recurrence Score Test Market Size by Type (2016-2027)
6.3 North America Breast Cancer Recurrence Score Test Market Size by Application
6.3.1 North America Breast Cancer Recurrence Score Test Market Size by Application (2016-2021)
6.3.2 North America Breast Cancer Recurrence Score Test Market Size by Application (2022-2027)
6.3.3 North America Breast Cancer Recurrence Score Test Market Size by Application (2016-2027)
6.4 North America Breast Cancer Recurrence Score Test Market Size by Country
6.4.1 North America Breast Cancer Recurrence Score Test Market Size by Country (2016-2021)
6.4.2 North America Breast Cancer Recurrence Score Test Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Breast Cancer Recurrence Score Test Market Size (2016-2027)
7.2 Europe Breast Cancer Recurrence Score Test Market Size by Type
7.2.1 Europe Breast Cancer Recurrence Score Test Market Size by Type (2016-2021)
7.2.2 Europe Breast Cancer Recurrence Score Test Market Size by Type (2022-2027)
7.2.3 Europe Breast Cancer Recurrence Score Test Market Size by Type (2016-2027)
7.3 Europe Breast Cancer Recurrence Score Test Market Size by Application
7.3.1 Europe Breast Cancer Recurrence Score Test Market Size by Application (2016-2021)
7.3.2 Europe Breast Cancer Recurrence Score Test Market Size by Application (2022-2027)
7.3.3 Europe Breast Cancer Recurrence Score Test Market Size by Application (2016-2027)
7.4 Europe Breast Cancer Recurrence Score Test Market Size by Country
7.4.1 Europe Breast Cancer Recurrence Score Test Market Size by Country (2016-2021)
7.4.2 Europe Breast Cancer Recurrence Score Test Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Breast Cancer Recurrence Score Test Market Size (2016-2027)
8.2 Asia-Pacific Breast Cancer Recurrence Score Test Market Size by Type
8.2.1 Asia-Pacific Breast Cancer Recurrence Score Test Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Breast Cancer Recurrence Score Test Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Breast Cancer Recurrence Score Test Market Size by Type (2016-2027)
8.3 Asia-Pacific Breast Cancer Recurrence Score Test Market Size by Application
8.3.1 Asia-Pacific Breast Cancer Recurrence Score Test Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Breast Cancer Recurrence Score Test Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Breast Cancer Recurrence Score Test Market Size by Application (2016-2027)
8.4 Asia-Pacific Breast Cancer Recurrence Score Test Market Size by Region
8.4.1 Asia-Pacific Breast Cancer Recurrence Score Test Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Breast Cancer Recurrence Score Test Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Breast Cancer Recurrence Score Test Market Size (2016-2027)
9.2 Latin America Breast Cancer Recurrence Score Test Market Size by Type
9.2.1 Latin America Breast Cancer Recurrence Score Test Market Size by Type (2016-2021)
9.2.2 Latin America Breast Cancer Recurrence Score Test Market Size by Type (2022-2027)
9.2.3 Latin America Breast Cancer Recurrence Score Test Market Size by Type (2016-2027)
9.3 Latin America Breast Cancer Recurrence Score Test Market Size by Application
9.3.1 Latin America Breast Cancer Recurrence Score Test Market Size by Application (2016-2021)
9.3.2 Latin America Breast Cancer Recurrence Score Test Market Size by Application (2022-2027)
9.3.3 Latin America Breast Cancer Recurrence Score Test Market Size by Application (2016-2027)
9.4 Latin America Breast Cancer Recurrence Score Test Market Size by Country
9.4.1 Latin America Breast Cancer Recurrence Score Test Market Size by Country (2016-2021)
9.4.2 Latin America Breast Cancer Recurrence Score Test Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Breast Cancer Recurrence Score Test Market Size (2016-2027)
10.2 Middle East & Africa Breast Cancer Recurrence Score Test Market Size by Type
10.2.1 Middle East & Africa Breast Cancer Recurrence Score Test Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Breast Cancer Recurrence Score Test Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Breast Cancer Recurrence Score Test Market Size by Type (2016-2027)
10.3 Middle East & Africa Breast Cancer Recurrence Score Test Market Size by Application
10.3.1 Middle East & Africa Breast Cancer Recurrence Score Test Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Breast Cancer Recurrence Score Test Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Breast Cancer Recurrence Score Test Market Size by Application (2016-2027)
10.4 Middle East & Africa Breast Cancer Recurrence Score Test Market Size by Country
10.4.1 Middle East & Africa Breast Cancer Recurrence Score Test Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Breast Cancer Recurrence Score Test Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Roche Diagnostics
11.1.1 Roche Diagnostics Company Details
11.1.2 Roche Diagnostics Business Overview
11.1.3 Roche Diagnostics Breast Cancer Recurrence Score Test Introduction
11.1.4 Roche Diagnostics Revenue in Breast Cancer Recurrence Score Test Business (2016-2021)
11.1.5 Roche Diagnostics Recent Development
11.2 Braster
11.2.1 Braster Company Details
11.2.2 Braster Business Overview
11.2.3 Braster Breast Cancer Recurrence Score Test Introduction
11.2.4 Braster Revenue in Breast Cancer Recurrence Score Test Business (2016-2021)
11.2.5 Braster Recent Development
11.3 Bremed
11.3.1 Bremed Company Details
11.3.2 Bremed Business Overview
11.3.3 Bremed Breast Cancer Recurrence Score Test Introduction
11.3.4 Bremed Revenue in Breast Cancer Recurrence Score Test Business (2016-2021)
11.3.5 Bremed Recent Development
11.4 Forward Science Technologies
11.4.1 Forward Science Technologies Company Details
11.4.2 Forward Science Technologies Business Overview
11.4.3 Forward Science Technologies Breast Cancer Recurrence Score Test Introduction
11.4.4 Forward Science Technologies Revenue in Breast Cancer Recurrence Score Test Business (2016-2021)
11.4.5 Forward Science Technologies Recent Development
11.5 Guided Therapeutics
11.5.1 Guided Therapeutics Company Details
11.5.2 Guided Therapeutics Business Overview
11.5.3 Guided Therapeutics Breast Cancer Recurrence Score Test Introduction
11.5.4 Guided Therapeutics Revenue in Breast Cancer Recurrence Score Test Business (2016-2021)
11.5.5 Guided Therapeutics Recent Development
11.6 Varian Medical Systems
11.6.1 Varian Medical Systems Company Details
11.6.2 Varian Medical Systems Business Overview
11.6.3 Varian Medical Systems Breast Cancer Recurrence Score Test Introduction
11.6.4 Varian Medical Systems Revenue in Breast Cancer Recurrence Score Test Business (2016-2021)
11.6.5 Varian Medical Systems Recent Development
11.7 LED Dental
11.7.1 LED Dental Company Details
11.7.2 LED Dental Business Overview
11.7.3 LED Dental Breast Cancer Recurrence Score Test Introduction
11.7.4 LED Dental Revenue in Breast Cancer Recurrence Score Test Business (2016-2021)
11.7.5 LED Dental Recent Development
11.8 PWB Health
11.8.1 PWB Health Company Details
11.8.2 PWB Health Business Overview
11.8.3 PWB Health Breast Cancer Recurrence Score Test Introduction
11.8.4 PWB Health Revenue in Breast Cancer Recurrence Score Test Business (2016-2021)
11.8.5 PWB Health Recent Development
11.9 Zilico Medical Diagnostics
11.9.1 Zilico Medical Diagnostics Company Details
11.9.2 Zilico Medical Diagnostics Business Overview
11.9.3 Zilico Medical Diagnostics Breast Cancer Recurrence Score Test Introduction
11.9.4 Zilico Medical Diagnostics Revenue in Breast Cancer Recurrence Score Test Business (2016-2021)
11.9.5 Zilico Medical Diagnostics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Breast Cancer Recurrence Score Test Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Stage I Invasive Breast Cancer
Table 3. Key Players of Stage II Invasive Breast Cancer
Table 4. Key Players of Estrogen Receptor-positive Cancer
Table 5. Key Players of Lymph Node-negative Breast Cancer
Table 6. Global Breast Cancer Recurrence Score Test Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Breast Cancer Recurrence Score Test Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Breast Cancer Recurrence Score Test Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Breast Cancer Recurrence Score Test Market Share by Regions (2016-2021)
Table 10. Global Breast Cancer Recurrence Score Test Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Breast Cancer Recurrence Score Test Market Share by Regions (2022-2027)
Table 12. Breast Cancer Recurrence Score Test Market Trends
Table 13. Breast Cancer Recurrence Score Test Market Drivers
Table 14. Breast Cancer Recurrence Score Test Market Challenges
Table 15. Breast Cancer Recurrence Score Test Market Restraints
Table 16. Global Breast Cancer Recurrence Score Test Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Breast Cancer Recurrence Score Test Market Share by Players (2016-2021)
Table 18. Global Top Breast Cancer Recurrence Score Test Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Breast Cancer Recurrence Score Test as of 2020)
Table 19. Ranking of Global Top Breast Cancer Recurrence Score Test Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Breast Cancer Recurrence Score Test Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Breast Cancer Recurrence Score Test Product Solution and Service
Table 23. Date of Enter into Breast Cancer Recurrence Score Test Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Breast Cancer Recurrence Score Test Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Breast Cancer Recurrence Score Test Revenue Market Share by Type (2016-2021)
Table 27. Global Breast Cancer Recurrence Score Test Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Breast Cancer Recurrence Score Test Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Breast Cancer Recurrence Score Test Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Breast Cancer Recurrence Score Test Revenue Market Share by Application (2016-2021)
Table 31. Global Breast Cancer Recurrence Score Test Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Breast Cancer Recurrence Score Test Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Breast Cancer Recurrence Score Test Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Breast Cancer Recurrence Score Test Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Breast Cancer Recurrence Score Test Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Breast Cancer Recurrence Score Test Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Breast Cancer Recurrence Score Test Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Breast Cancer Recurrence Score Test Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Breast Cancer Recurrence Score Test Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Breast Cancer Recurrence Score Test Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Breast Cancer Recurrence Score Test Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Breast Cancer Recurrence Score Test Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Breast Cancer Recurrence Score Test Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Breast Cancer Recurrence Score Test Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Breast Cancer Recurrence Score Test Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Breast Cancer Recurrence Score Test Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Breast Cancer Recurrence Score Test Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Breast Cancer Recurrence Score Test Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Breast Cancer Recurrence Score Test Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Breast Cancer Recurrence Score Test Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Breast Cancer Recurrence Score Test Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Breast Cancer Recurrence Score Test Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Breast Cancer Recurrence Score Test Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Breast Cancer Recurrence Score Test Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Breast Cancer Recurrence Score Test Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Breast Cancer Recurrence Score Test Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Breast Cancer Recurrence Score Test Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Breast Cancer Recurrence Score Test Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Breast Cancer Recurrence Score Test Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Breast Cancer Recurrence Score Test Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Breast Cancer Recurrence Score Test Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Breast Cancer Recurrence Score Test Market Size by Country (2022-2027) & (US$ Million)
Table 63. Roche Diagnostics Company Details
Table 64. Roche Diagnostics Business Overview
Table 65. Roche Diagnostics Breast Cancer Recurrence Score Test Product
Table 66. Roche Diagnostics Revenue in Breast Cancer Recurrence Score Test Business (2016-2021) & (US$ Million)
Table 67. Roche Diagnostics Recent Development
Table 68. Braster Company Details
Table 69. Braster Business Overview
Table 70. Braster Breast Cancer Recurrence Score Test Product
Table 71. Braster Revenue in Breast Cancer Recurrence Score Test Business (2016-2021) & (US$ Million)
Table 72. Braster Recent Development
Table 73. Bremed Company Details
Table 74. Bremed Business Overview
Table 75. Bremed Breast Cancer Recurrence Score Test Product
Table 76. Bremed Revenue in Breast Cancer Recurrence Score Test Business (2016-2021) & (US$ Million)
Table 77. Bremed Recent Development
Table 78. Forward Science Technologies Company Details
Table 79. Forward Science Technologies Business Overview
Table 80. Forward Science Technologies Breast Cancer Recurrence Score Test Product
Table 81. Forward Science Technologies Revenue in Breast Cancer Recurrence Score Test Business (2016-2021) & (US$ Million)
Table 82. Forward Science Technologies Recent Development
Table 83. Guided Therapeutics Company Details
Table 84. Guided Therapeutics Business Overview
Table 85. Guided Therapeutics Breast Cancer Recurrence Score Test Product
Table 86. Guided Therapeutics Revenue in Breast Cancer Recurrence Score Test Business (2016-2021) & (US$ Million)
Table 87. Guided Therapeutics Recent Development
Table 88. Varian Medical Systems Company Details
Table 89. Varian Medical Systems Business Overview
Table 90. Varian Medical Systems Breast Cancer Recurrence Score Test Product
Table 91. Varian Medical Systems Revenue in Breast Cancer Recurrence Score Test Business (2016-2021) & (US$ Million)
Table 92. Varian Medical Systems Recent Development
Table 93. LED Dental Company Details
Table 94. LED Dental Business Overview
Table 95. LED Dental Breast Cancer Recurrence Score Test Product
Table 96. LED Dental Revenue in Breast Cancer Recurrence Score Test Business (2016-2021) & (US$ Million)
Table 97. LED Dental Recent Development
Table 98. PWB Health Company Details
Table 99. PWB Health Business Overview
Table 100. PWB Health Revenue in Breast Cancer Recurrence Score Test Business (2016-2021) & (US$ Million)
Table 101. PWB Health Recent Development
Table 102. Zilico Medical Diagnostics Company Details
Table 103. Zilico Medical Diagnostics Business Overview
Table 104. Zilico Medical Diagnostics Breast Cancer Recurrence Score Test Product
Table 105. Zilico Medical Diagnostics Revenue in Breast Cancer Recurrence Score Test Business (2016-2021) & (US$ Million)
Table 106. Zilico Medical Diagnostics Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Breast Cancer Recurrence Score Test Market Share by Type: 2020 VS 2027
Figure 2. Stage I Invasive Breast Cancer Features
Figure 3. Stage II Invasive Breast Cancer Features
Figure 4. Estrogen Receptor-positive Cancer Features
Figure 5. Lymph Node-negative Breast Cancer Features
Figure 6. Global Breast Cancer Recurrence Score Test Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Speciality Cancer Centers Case Studies
Figure 9. Advanced Diagnostic Centers Case Studies
Figure 10. Others Case Studies
Figure 11. Breast Cancer Recurrence Score Test Report Years Considered
Figure 12. Global Breast Cancer Recurrence Score Test Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Breast Cancer Recurrence Score Test Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Breast Cancer Recurrence Score Test Market Share by Regions: 2020 VS 2027
Figure 15. Global Breast Cancer Recurrence Score Test Market Share by Regions (2022-2027)
Figure 16. Global Breast Cancer Recurrence Score Test Market Share by Players in 2020
Figure 17. Global Top Breast Cancer Recurrence Score Test Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Breast Cancer Recurrence Score Test as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Breast Cancer Recurrence Score Test Revenue in 2020
Figure 19. Global Breast Cancer Recurrence Score Test Revenue Market Share by Type (2016-2021)
Figure 20. Global Breast Cancer Recurrence Score Test Revenue Market Share by Type (2022-2027)
Figure 21. North America Breast Cancer Recurrence Score Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Breast Cancer Recurrence Score Test Market Share by Type (2016-2027)
Figure 23. North America Breast Cancer Recurrence Score Test Market Share by Application (2016-2027)
Figure 24. North America Breast Cancer Recurrence Score Test Market Share by Country (2016-2027)
Figure 25. United States Breast Cancer Recurrence Score Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Breast Cancer Recurrence Score Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Breast Cancer Recurrence Score Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Breast Cancer Recurrence Score Test Market Share by Type (2016-2027)
Figure 29. Europe Breast Cancer Recurrence Score Test Market Share by Application (2016-2027)
Figure 30. Europe Breast Cancer Recurrence Score Test Market Share by Country (2016-2027)
Figure 31. Germany Breast Cancer Recurrence Score Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Breast Cancer Recurrence Score Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Breast Cancer Recurrence Score Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Breast Cancer Recurrence Score Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Breast Cancer Recurrence Score Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Breast Cancer Recurrence Score Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Breast Cancer Recurrence Score Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Breast Cancer Recurrence Score Test Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Breast Cancer Recurrence Score Test Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Breast Cancer Recurrence Score Test Market Share by Region (2016-2027)
Figure 41. China Breast Cancer Recurrence Score Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Breast Cancer Recurrence Score Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Breast Cancer Recurrence Score Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Breast Cancer Recurrence Score Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Breast Cancer Recurrence Score Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Breast Cancer Recurrence Score Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Breast Cancer Recurrence Score Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Breast Cancer Recurrence Score Test Market Share by Type (2016-2027)
Figure 49. Latin America Breast Cancer Recurrence Score Test Market Share by Application (2016-2027)
Figure 50. Latin America Breast Cancer Recurrence Score Test Market Share by Country (2016-2027)
Figure 51. Mexico Breast Cancer Recurrence Score Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Breast Cancer Recurrence Score Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Breast Cancer Recurrence Score Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Breast Cancer Recurrence Score Test Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Breast Cancer Recurrence Score Test Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Breast Cancer Recurrence Score Test Market Share by Country (2016-2027)
Figure 57. Turkey Breast Cancer Recurrence Score Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Breast Cancer Recurrence Score Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Breast Cancer Recurrence Score Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Roche Diagnostics Revenue Growth Rate in Breast Cancer Recurrence Score Test Business (2016-2021)
Figure 61. Braster Revenue Growth Rate in Breast Cancer Recurrence Score Test Business (2016-2021)
Figure 62. Bremed Revenue Growth Rate in Breast Cancer Recurrence Score Test Business (2016-2021)
Figure 63. Forward Science Technologies Revenue Growth Rate in Breast Cancer Recurrence Score Test Business (2016-2021)
Figure 64. Guided Therapeutics Revenue Growth Rate in Breast Cancer Recurrence Score Test Business (2016-2021)
Figure 65. Varian Medical Systems Revenue Growth Rate in Breast Cancer Recurrence Score Test Business (2016-2021)
Figure 66. LED Dental Revenue Growth Rate in Breast Cancer Recurrence Score Test Business (2016-2021)
Figure 67. PWB Health Revenue Growth Rate in Breast Cancer Recurrence Score Test Business (2016-2021)
Figure 68. Zilico Medical Diagnostics Revenue Growth Rate in Breast Cancer Recurrence Score Test Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---